An inhibitor of VMAT2
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Valbenazine is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy, and inhibits VMAT2 function.
Valbenazine shows a distinctive improvement in tardive dyskinesia symptoms during the successful Phase II trial[1].
参考文献:
[1]. Müller T, et al. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Expert Opin Investig Drugs. 2015 Jun;24(6):737-42.
Azilsartan medoxomil monopotassium
¥330.00 ¥412.00
没有评价数据